You can:
Name | 5-hydroxytryptamine receptor 2B |
---|---|
Species | Homo sapiens (Human) |
Gene | HTR2B |
Synonym | stomach fundus serotonin receptor serotonin receptor 2B 5-HT2F 5-HT-2B 5-HT2B [ Show all ] |
Disease | Psychoses Migraine Irritable bowel syndrome Depression; Cerebral infarction Coronary heart disease [ Show all ] |
Length | 481 |
Amino acid sequence | MALSYRVSELQSTIPEHILQSTFVHVISSNWSGLQTESIPEEMKQIVEEQGNKLHWAALLILMVIIPTIGGNTLVILAVSLEKKLQYATNYFLMSLAVADLLVGLFVMPIALLTIMFEAMWPLPLVLCPAWLFLDVLFSTASIMHLCAISVDRYIAIKKPIQANQYNSRATAFIKITVVWLISIGIAIPVPIKGIETDVDNPNNITCVLTKERFGDFMLFGSLAAFFTPLAIMIVTYFLTIHALQKKAYLVKNKPPQRLTWLTVSTVFQRDETPCSSPEKVAMLDGSRKDKALPNSGDETLMRRTSTIGKKSVQTISNEQRASKVLGIVFFLFLLMWCPFFITNITLVLCDSCNQTTLQMLLEIFVWIGYVSSGVNPLVYTLFNKTFRDAFGRYITCNYRATKSVKTLRKRSSKIYFRNPMAENSKFFKKHGIRNGINPAMYQSPMRLRSSTIQSSSIILLDTLLLTENEGDKTEEQVSYV |
UniProt | P41595 |
Protein Data Bank | 5tud, 5tvn, 6drx, 4ib4, 4nc3, 6dry, 6drz, 6ds0 |
GPCR-HGmod model | P41595 |
3D structure model | This structure is from PDB ID 5tud. |
BioLiP | BL0425280, BL0425283, BL0425282, BL0239858, BL0239859, BL0265182, BL0265183, BL0368464, BL0425281, BL0385686,BL0385687, BL0425284, BL0425285, BL0425286, BL0368465, BL0425287 |
Therapeutic Target Database | T31204 |
ChEMBL | CHEMBL1833 |
IUPHAR | 7 |
DrugBank | BE0000393 |
Name | 1-(3-Chlorophenyl)piperazine |
---|---|
Molecular formula | C10H13ClN2 |
IUPAC name | 1-(3-chlorophenyl)piperazine |
Molecular weight | 196.678 |
Hydrogen bond acceptor | 2 |
Hydrogen bond donor | 1 |
XlogP | 1.7 |
Synonyms | 1-(3-Chloro Phenyl)Piperazine N-(m-Chlorophenyl)piperazine 1-3-CPP NCGC00024836-02 4-(m-chlorophenyl)piperazine [ Show all ] |
Inchi Key | VHFVKMTVMIZMIK-UHFFFAOYSA-N |
Inchi ID | InChI=1S/C10H13ClN2/c11-9-2-1-3-10(8-9)13-6-4-12-5-7-13/h1-3,8,12H,4-7H2 |
PubChem CID | 1355 |
ChEMBL | CHEMBL478 |
IUPHAR | 142 |
BindingDB | 50001915 |
DrugBank | DB12110 |
Structure | ![]() |
Lipinski's druglikeness | This ligand satisfies Lipinski's rule of five. |
Parameter | Value | Reference | Database source |
---|---|---|---|
EC50 | <1000.0 nM | PMID16257207, PMID15081042 | BindingDB,ChEMBL |
EC50 | 39.81 nM | PMID18095642, PMID27864071 | ChEMBL |
EC50 | 40.0 nM | PMID27864071 | BindingDB |
EC50 | 125.0 nM | PMID19646865, PMID19716297 | BindingDB,ChEMBL |
EC50 | 287.0 nM | PMID20022752, PMID17315987 | BindingDB,ChEMBL |
Efficacy | 33.0 % | PMID16257207 | ChEMBL |
Emax | 22.0 % | PMID27864071 | ChEMBL |
Emax | 35.0 % | PMID19646865, PMID19716297 | ChEMBL |
Intrinsic activity | 0.4 - | PMID20022752 | ChEMBL |
Ki | 3.16228 - 39.8107 nM | PMID15322733, PMID11104741, PMID9933142, PMID9459568, PMID12970106 | IUPHAR |
Ki | 3.2 nM | PMID11104741 | PDSP,BindingDB |
Ki | 10.0 nM | PMID27864071 | ChEMBL |
Ki | 10.0 nM | PMID27864071 | BindingDB |
Ki | 10.5 nM | PMID9459568 | PDSP,BindingDB |
Ki | 12.02 nM | PMID11882920 | BindingDB |
Ki | 12.0226 nM | PMID11882920 | PDSP |
Ki | 19.9 nM | http://pdsp.med.unc.edu/pdsp.php | PDSP |
Ki | 24.0 nM | PMID20022752, PMID17315987 | BindingDB,ChEMBL |
Ki | 28.7 nM | PMID8632342 | PDSP,BindingDB |
Ki | 28.8 nM | PMID9459568 | PDSP,BindingDB |
Ki | 31.62 nM | PMID7582481 | PDSP,BindingDB |
Ki | 32.0 nM | PMID16257207, PMID15081042 | PDSP,BindingDB,ChEMBL |
Ki | 37.15 nM | PMID9225287 | PDSP,BindingDB |
Ki | 40.0 nM | PMID14709324 | PDSP,BindingDB |
Ki | 40.738 nM | PMID15322733 | PDSP |
Ki | 40.74 nM | PMID15322733 | BindingDB |
Ki | 63.0957 nM | PMID10498829 | PDSP |
Ki | 63.1 nM | PMID10498829 | BindingDB |
Relative efficacy | 33.0 % | PMID15081042 | ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417